DongKoo Bio&Pharma Co. Ltd (006620) — Net Asset Quality Index
DongKoo Bio&Pharma Co. Ltd (006620) has a Net Asset Quality Index of 41.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩269.00 Billion minus total liabilities of ₩158.34 Billion yields net assets of ₩110.66 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 006620 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
DongKoo Bio&Pharma Co. Ltd Net Asset Quality Index Over Time (2015–2024)
This chart shows how DongKoo Bio&Pharma Co. Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2015 to 2024. As of September 2025, the index stands at 41.1%, representing net assets of ₩110.66 Billion against total assets of ₩269.00 Billion KRW. See DongKoo Bio&Pharma Co. Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for DongKoo Bio&Pharma Co. Ltd (2015–2024)
The table below presents the year-by-year Net Asset Quality Index for DongKoo Bio&Pharma Co. Ltd from 2015 to 2024, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is DongKoo Bio&Pharma Co. Ltd worth.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 43.2% | ₩105.33 Billion | ₩244.06 Billion | ₩138.73 Billion | ▼ -14.6 pp |
| 2023 | 57.8% | ₩110.44 Billion | ₩191.10 Billion | ₩80.66 Billion | ▼ -1.6 pp |
| 2022 | 59.3% | ₩102.11 Billion | ₩172.06 Billion | ₩69.95 Billion | ▼ -5.3 pp |
| 2021 | 64.7% | ₩100.12 Billion | ₩154.79 Billion | ₩54.66 Billion | ▼ -0.9 pp |
| 2020 | 65.6% | ₩94.65 Billion | ₩144.35 Billion | ₩49.70 Billion | ▲ +1.0 pp |
| 2019 | 64.5% | ₩85.65 Billion | ₩132.73 Billion | ₩47.07 Billion | ▼ -4.6 pp |
| 2018 | 69.1% | ₩72.10 Billion | ₩104.28 Billion | ₩32.18 Billion | ▲ +19.2 pp |
| 2017 | 49.9% | ₩37.74 Billion | ₩75.59 Billion | ₩37.85 Billion | ▲ +16.2 pp |
| 2016 | 33.8% | ₩22.05 Billion | ₩65.31 Billion | ₩43.27 Billion | ▲ +29.6 pp |
| 2015 | 4.2% | ₩2.55 Billion | ₩60.77 Billion | ₩58.22 Billion | — |